A new report from the Presidential Commission on Bioethics calls for "prudent vigilance" and enhanced federal oversight of synthetic biology. The Commission calls for high level engagement and places responsibility on the Executive Office.
The Synthetic Biology Newsletter is an initiative of LIS Consult and the Synthetic Biology Project of the Woodrow Wilson International Center for Scholars. The newsletter is financially supported by the Commission on Genetic Modification and the Rathenau Institute, both in the Netherlands.
Workshop hosted by the Alfred R. Sloan Foundation, the U.S. Department of Energy, and the Woodrow Wilson International Center for Scholars
November 8-9, 2010
A new Eurobarometer survey on life sciences and biotechnology shows that Europeans are optimistic about biotechnology. 53% of respondents believe biotechnology will have a positive effect in the future, and only 20% a negative effect.
Super Cell is a fictional supermarket offering speculative products, which are all based on synthetic biology.
Regarding the specifics of synthetic biology, Science Daily wrote in a Nov. 5, 2010 press release, “The University of Greenwich’s School of Architecture & Construction is poised to use ethical synthetic biology to create ‘living’ materials that could be used to clad buildings and help combat the effects of climate change.
Three international drug companies have announced strategic moves to strengthen their position in the booming Chinese health care market.
College and high school students from the world over begin convening in Boston today for the International Genetically Engineered Machine (iGEM) competition to present biotech projects they’ve been working on all summer.
Researchers are working with the University of Southern Denmark, theUniversity of Glasgow and University College London (UCL) to develop building materials that could produce water in desert environments or harvest sunlight to make biofuels.
Synthetic Genomics (SGI) and the J. Craig Venter Institute (JCVI) have formed a new company, Synthetic Genomics Vaccines (SGVI), to develop next-generation vaccines based on synthetic genome technology.
New Yorkers brought in the autumnal equinox in style September 25th and 26th at the 2010 Maker Faire.
Melanie Swan did not panic upon learning she had inherited a genetic mutation that seemed to put her at a higher risk of heart attack and cardiovascular disease. Instead she and another "garage biologist" ran a pilot study from their own homes and came up with a countermeasure.